Impact of Three Months Metformin Treatment on VLDL-TG Metabolism in Healthy Subjects and Patients with Type 2 Diabetes

被引:0
|
作者
Gormsen, Lars C.
Sondergaard, Esben
Christensen, Nana
Tolbod, Lars P.
Nielsen, Soren
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1952-P
引用
收藏
页码:A516 / A516
页数:1
相关论文
共 50 条
  • [31] Effects of diabetes type 2 and metformin treatment in Swedish patients with colorectal cancer
    Dimberg, Jan
    Shamoun, Levar
    Landerholm, Kalle
    Wagsaeter, Dick
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (19) : 2148 - 2151
  • [32] Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy
    Fu, A. Z.
    Qiu, Y.
    Davies, M. J.
    Radican, L.
    Engel, S. S.
    DIABETES OBESITY & METABOLISM, 2011, 13 (08): : 765 - 769
  • [33] Efficacy and safety of metformin for treatment of type 2 diabetes in elderly Japanese patients
    Ito, Hiroyuki
    Ohno, Yasuhiro
    Yamauchi, Takaaki
    Kawabata, Yumiko
    Ikegami, Hiroshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2011, 11 (01) : 55 - 62
  • [34] PROFILES OF CIRCULATING miRNAs FOLLOWING METFORMIN TREATMENT IN PATIENTS WITH TYPE 2 DIABETES
    Demirsoy, Ibrahim Halil
    Ertural, Duygu Yolal
    Balci, Senay
    Cinkir, Umit
    Sezer, Kerem
    Tamer, Lulufer
    Aras, Nurcan
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2018, 37 (04) : 499 - 506
  • [35] Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes
    Asagami, T
    Abbasi, F
    Stuelinger, M
    Lamendola, C
    McLaughlin, T
    Cooke, JP
    Reaven, GM
    Tsao, PS
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (07): : 843 - 846
  • [36] Variability in the therapeutic response of Metformin treatment in patients with type 2 diabetes mellitus
    Rashid, Maryam
    Shahzad, Muhammad
    Mahmood, Saqib
    Khan, Khurshid
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2019, 35 (01) : 71 - 76
  • [37] Metformin/rosiglitazone combination pill (Avandamet®) for the treatment of patients with Type 2 diabetes
    Smiley, Dawn
    Umpierrez, Guillermo
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) : 1353 - 1364
  • [38] Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin
    Chamarthi, Bindu
    Ezrokhi, Michael
    Rutty, Dean
    Cincotta, Anthony H.
    POSTGRADUATE MEDICINE, 2016, 128 (08) : 761 - 769
  • [39] Glucagonostatic Potency of GLP-1 in Patients With Type 2 Diabetes, Patients With Type 1 Diabetes, and Healthy Control Subjects
    Bagger, Jonatan, I
    Grondahl, Magnus F. G.
    Lund, Asger
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES, 2021, 70 (06) : 1347 - 1356
  • [40] Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
    Judith J. Gout-Zwart
    Lisa A. de Jong
    Lisanne Saptenno
    Maarten J. Postma
    PharmacoEconomics - Open, 2020, 4 : 321 - 330